Nano based drug delivery systems: recent developments and future prospects
JK Patra, G Das, LF Fraceto, EVR Campos… - Journal of …, 2018 - Springer
Nanomedicine and nano delivery systems are a relatively new but rapidly developing
science where materials in the nanoscale range are employed to serve as means of …
science where materials in the nanoscale range are employed to serve as means of …
Stimuli-responsive polymeric nanocarriers for drug delivery, imaging, and theragnosis
In the past few decades, polymeric nanocarriers have been recognized as promising tools
and have gained attention from researchers for their potential to efficiently deliver bioactive …
and have gained attention from researchers for their potential to efficiently deliver bioactive …
Dendrimers as pharmaceutical excipients: synthesis, properties, toxicity and biomedical applications
The European Medicines Agency (EMA) and the Current Good Manufacturing Practices
(cGMP) in the United States of America, define excipient as the constituents of the …
(cGMP) in the United States of America, define excipient as the constituents of the …
Stimulus-responsive sequential release systems for drug and gene delivery
S Ahmadi, N Rabiee, M Bagherzadeh, F Elmi, Y Fatahi… - Nano today, 2020 - Elsevier
In recent years, a range of studies have been conducted with the aim to design and
characterize delivery systems that are able to release multiple therapeutic agents in …
characterize delivery systems that are able to release multiple therapeutic agents in …
BCS class IV drugs: Highly notorious candidates for formulation development
BCS class IV drugs (eg, amphotericin B, furosemide, acetazolamide, ritonavir, paclitaxel)
exhibit many characteristics that are problematic for effective oral and per oral delivery …
exhibit many characteristics that are problematic for effective oral and per oral delivery …
RGD engineered dendrimer nanotherapeutic as an emerging targeted approach in cancer therapy
A bird's eye view is now demanded in the area of cancer research to suppress the suffering
of cancer patient and mediate the lack of treatment related to chemotherapy. Chemotherapy …
of cancer patient and mediate the lack of treatment related to chemotherapy. Chemotherapy …
Therapeutic targeting of non-coding RNAs in cancer
O Slaby, R Laga, O Sedlacek - Biochemical journal, 2017 - portlandpress.com
The majority of the human genome encodes RNAs that do not code for proteins. These non-
coding RNAs (ncRNAs) affect normal expression of the genes, including oncogenes and …
coding RNAs (ncRNAs) affect normal expression of the genes, including oncogenes and …
Dendrimers designed for functions: from physical, photophysical, and supramolecular properties to applications in sensing, catalysis, molecular electronics, photonics …
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular
Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and …
Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and …
Oral delivery of anticancer drugs: challenges and opportunities
The present report focuses on the various aspects of oral delivery of anticancer drugs. The
significance of oral delivery in cancer therapeutics has been highlighted which principally …
significance of oral delivery in cancer therapeutics has been highlighted which principally …
Polymeric conjugates for drug delivery
N Larson, H Ghandehari - Chemistry of Materials, 2012 - ACS Publications
The field of polymer therapeutics has evolved over the past decade and has resulted in the
development of polymer–drug conjugates with a wide variety of architectures and chemical …
development of polymer–drug conjugates with a wide variety of architectures and chemical …